Avid Bioservices Receives Five 2020 CMO Leadership Awards
March 26, 2020 08:05 ET
|
Avid Bioservices, Inc
Company Honored for Capabilities, Expertise, Reliability, Compatibility, and Service in the Contract Development and Manufacturing Industry Named 2020 CMO Leadership Award Champion in Categories of...
Avid Bioservices Reports Financial Results for Third Quarter Fiscal 2020 and Recent Developments
March 10, 2020 16:05 ET
|
Avid Bioservices, Inc
-- Recorded Third Quarter Revenue of $13.6 Million -- -- Signed New Customer and Project Expansion Orders with Current Customers for $20 Million -- -- Adjusting Fiscal 2020 Projected Revenue to $55...
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
March 04, 2020 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., March 04, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2020 After Market Close on March 10, 2020
March 03, 2020 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., March 03, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices Appoints Timothy Compton as Chief Commercial Officer
January 08, 2020 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2020 and Recent Developments
December 09, 2019 16:05 ET
|
Avid Bioservices, Inc
-- Achieved Strong Second Quarter Revenue of $18.3 Million and Gross Margin of 18% -- -- Fiscal 2020 Projected Revenue of $64 to $67 Million Reaffirmed -- -- Launched Expanded Process Development...
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
December 04, 2019 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Dec. 04, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices Names Richard Richieri as Chief Operations Officer
October 09, 2019 12:30 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Oct. 09, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices Announces Completion of Expansion of Process Development Capabilities and Laboratory Infrastructure
October 08, 2019 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Oct. 08, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices Announces Termination of Stockholder Rights Plan
September 23, 2019 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...